NCT06085092 Open vs. Blind Weighing Study In Adolescents and Young Adult With Eating Disorders
| NCT ID | NCT06085092 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Milton S. Hershey Medical Center |
| Condition | Eating Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2023-10-31 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2023-10-31 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Current treatments for adolescents and young adults (AYAs) with eating disorders (EDs) do not effectively address a central ED symptom - anxiety about weight gain - which contributes to poor outcomes. The proposed study evaluates the feasibility, acceptability, efficacy, and underlying mechanisms of an enhanced version of "open weighing," a cognitive-behavioral intervention designed to target anxiety about weight gain in AYAs with EDs. Understanding how to better treat AYAs with EDs, and identifying the mechanisms by which interventions lead to improvement, will aid in the development of more effective and personalized treatments, ultimately improving the lives of AYAs with EDs.
Eligibility Criteria
Inclusion Criteria: * Participants must be English speakers. * Participants must be between the ages of 12 - 24 years who have been admitted to either the adolescent or young adult Partial Hospital Program (PHP) for eating disorders (EDs) at Penn State Hershey. * Participants must also present with an eating disorder (ED) diagnosis that is characterized by anxiety about weight gain, such as anorexia nervosa (AN), Bulimia nervosa (BN), or their subthreshold presentations captured under the other specific feeding or eating disorder (OSFED) category. Exclusion Criteria: * Participants will be excluded if they are above the age of 24 or below the age of 12 years. * Participants who have been identified as non-English speakers. * Participants with cognitive impairment will also be excluded from participation. * Potential participants will be excluded if they do not meet the diagnostic inclusion criteria noted above. * individuals with a diagnosis of avoidant/restrictive food intake disorder, as these individuals do not experience anxiety about weight gain will be excluded.
Contact & Investigator
Jamal Essayli, Ph.D
PRINCIPAL INVESTIGATOR
Penn State University
Frequently Asked Questions
Who can join the NCT06085092 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 24 Years, studying Eating Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06085092 currently recruiting?
Yes, NCT06085092 is actively recruiting participants. Contact the research team at jessayli@pennstatehealth.psu.edu for enrollment information.
Where is the NCT06085092 trial being conducted?
This trial is being conducted at Hershey, United States.
Who is sponsoring the NCT06085092 clinical trial?
NCT06085092 is sponsored by Milton S. Hershey Medical Center. The principal investigator is Jamal Essayli, Ph.D at Penn State University. The trial plans to enroll 70 participants.